L.S. Volonteri

647 total citations
17 papers, 479 citations indexed

About

L.S. Volonteri is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, L.S. Volonteri has authored 17 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 6 papers in Pharmacology and 4 papers in Clinical Psychology. Recurrent topics in L.S. Volonteri's work include Schizophrenia research and treatment (10 papers), Bipolar Disorder and Treatment (8 papers) and Treatment of Major Depression (6 papers). L.S. Volonteri is often cited by papers focused on Schizophrenia research and treatment (10 papers), Bipolar Disorder and Treatment (8 papers) and Treatment of Major Depression (6 papers). L.S. Volonteri collaborates with scholars based in Italy, United States and Germany. L.S. Volonteri's co-authors include Massimo Carlo Mauri, A. Fiorentini, S.R. Bareggi, Alessandro Colasanti, Giancarlo Cerveri, Filippo Dragogna, Chiara Rovera, M. Maffini, Carlo Altamura and Massimo C. Mauri and has published in prestigious journals such as Psychopharmacology, Clinical Pharmacokinetics and Progress in Neuro-Psychopharmacology and Biological Psychiatry.

In The Last Decade

L.S. Volonteri

17 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L.S. Volonteri Italy	10	304	94	85	74	50	17	479
Silvia Paletta Italy	12	382 1.3×	128 1.4×	112 1.3×	96 1.3×	70 1.4×	29	673
P R Puopolo United States	9	254 0.8×	89 0.9×	47 0.6×	76 1.0×	43 0.9×	9	451
M. Maffini Italy	6	193 0.6×	69 0.7×	70 0.8×	78 1.1×	58 1.2×	7	392
Chiara Di Pace Italy	10	284 0.9×	96 1.0×	48 0.6×	71 1.0×	71 1.4×	16	499
Charles F. Caley United States	14	439 1.4×	139 1.5×	70 0.8×	99 1.3×	90 1.8×	27	806
Sidney S. Chang United States	11	460 1.5×	134 1.4×	79 0.9×	66 0.9×	48 1.0×	13	676
Jessica L. Gören United States	14	484 1.6×	112 1.2×	119 1.4×	43 0.6×	60 1.2×	28	719
Matthew A. Fuller United States	18	570 1.9×	167 1.8×	95 1.1×	51 0.7×	51 1.0×	52	835
Robert L. Dufresne United States	14	487 1.6×	105 1.1×	38 0.4×	61 0.8×	65 1.3×	33	720
John Guarino United States	12	299 1.0×	86 0.9×	42 0.5×	124 1.7×	41 0.8×	19	517

Countries citing papers authored by L.S. Volonteri

Since Specialization

Citations

This map shows the geographic impact of L.S. Volonteri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.S. Volonteri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.S. Volonteri more than expected).

Fields of papers citing papers by L.S. Volonteri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.S. Volonteri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.S. Volonteri. The network helps show where L.S. Volonteri may publish in the future.

Co-authorship network of co-authors of L.S. Volonteri

This figure shows the co-authorship network connecting the top 25 collaborators of L.S. Volonteri. A scholar is included among the top collaborators of L.S. Volonteri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.S. Volonteri. L.S. Volonteri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Fiorentini, A., L.S. Volonteri, Filippo Dragogna, et al.. (2011). Substance-Induced Psychoses: A Critical Review of the Literature. Current Drug Abuse Reviews. 4(4). 228–240. 60 indexed citations

Volonteri, L.S., et al.. (2010). Long-acting injectable risperidone and metabolic ratio: a possible index of clinical outcome in treatment-resistant schizophrenic patients. Psychopharmacology. 210(4). 489–497. 10 indexed citations

Mauri, Massimo Carlo, Martin R. Turner, L.S. Volonteri, Rossella Medori, & Wolfgang Maier. (2008). Dosing patterns in Europe: Efficacy and safety of risperidone long-acting injectable in doses of 25, 37.5 and 50 mg. International Journal of Psychiatry in Clinical Practice. 13(1). 36–47. 4 indexed citations

Mauri, Massimo Carlo, et al.. (2007). Clinical Pharmacokinetics of Atypical Antipsychotics. Clinical Pharmacokinetics. 46(5). 359–388. 197 indexed citations

Colasanti, Alessandro, et al.. (2007). Ziprasidone Outcome and Tolerability: A Practical Clinical Trial With Plasma Drug Levels. Pharmacopsychiatry. 40(3). 89–92. 8 indexed citations

Mauri, Massimo Carlo, et al.. (2007). Two weeks' quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder: a naturalistic study with drug plasma levels. Expert Opinion on Pharmacotherapy. 8(14). 2207–2213. 24 indexed citations

Mauri, Massimo Carlo, et al.. (2005). Acute, continuation and maintenance phases of antidepressant treatment. 46(2). 89–98. 2 indexed citations

Mauri, Massimo Carlo, et al.. (2005). Patterns of clinical use of antipsychotics in hospitalized psychiatric patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29(6). 957–963. 14 indexed citations

Cerveri, Giancarlo, et al.. (2005). Parasuicide and drug self-poisoning: analysis of the epidemiological and clinical variables of the patients admitted to the Poisoning Treatment Centre (CAV), Niguarda General Hospital, Milan. Clinical Practice and Epidemiology in Mental Health. 1(1). 5–5. 31 indexed citations

10.

Mauri, Massimo C., A. Fiorentini, Giancarlo Cerveri, et al.. (2003). Long‐term efficacy and therapeutic drug monitoring of sertraline in major depression. Human Psychopharmacology Clinical and Experimental. 18(5). 385–388. 14 indexed citations

11.

Mauri, Massimo Carlo, et al.. (2003). Predictors of Clinical Outcome in Schizophrenic Patients Responding to Clozapine. Journal of Clinical Psychopharmacology. 23(6). 660–664. 48 indexed citations

12.

Ruggiero, Giovanni Maria, et al.. (2003). Nutritional management of anorexic patients with and without fluoxetine: 1-year follow-up. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 27(3). 425–430. 9 indexed citations

13.

Mauri, Massimo C., et al.. (2002). Clinical outcome and tolerability of sertraline in major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 26(3). 597–601. 28 indexed citations

14.

Mauri, Maurizio, L.S. Volonteri, A. Fiorentini, et al.. (2002). Efficacy of clozapine in a non‐schizophrenic patient with psychogenic polydipsia and central pontine myelinolysis. Human Psychopharmacology Clinical and Experimental. 17(5). 253–255. 6 indexed citations

15.

Mauri, Massimo C., et al.. (2001). Predictive Value of Amino Acids in the Treatment of Major Depression with Fluvoxamine. Neuropsychobiology. 44(3). 134–138. 15 indexed citations

16.

Clemente, Antonio, et al.. (2001). "Postpsychotic depression" and residual schizophrenia in a mental health hospital.. PubMed. 26(6). 21–6. 5 indexed citations

17.

Mauri, Maurizio, et al.. (2000). Lithium safety in the prophylaxis of bipolar disorders: a study with plasma levels.. PubMed. 3(2). 63–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact